pharmacology Flashcards

1
Q

why might a woman be on medication during pregnancy, childbirth and lactation?

A
  • hypertension
  • migraine
  • asthma
  • mental health disorders
  • epilepsy
  • long term anticoagulant therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how can pregnancy affect pharmacokinetics of drugs

A

affects any of the four basic kinetic processes:

  • absorption
  • distribution
  • metabolism and elimination
  • excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe absorption changes during pregnancy

A

oral route: decrease in gastric emptying and gut motility

intramuscular route: blood flow increased = absorption increased

inhalation: increased cardiac output, decreased tidal volume = absorption increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe distribution changes during pregnancy

A

increased Vd: increase in plasma volume and fat

increased fraction of free drug: greater dilution of plasma will decrease relative amount of plasma proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe metabolism changes during pregnancy

A

oestrogen and progestogens can induce or inhibit liver P450 enzymes, increasing or reducing metabolism

eg phenytoin levels reduced due to induction of metabolism or theophylline levels increased due to inhibition of metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe excretion changes during pregnancy

A

GFR increased = increased excretion of many drugs

this can reduce the plasma concentration, and can necessitate an increase in dose of medicines cleared by the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how can pregnancy affect pharmacodynamics

A

pregnancy may affect:
site of drug action
- metabolites at sites of biological action (changes in blood flow)

receptor response to drug
- mechanism of action (changes in receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does placental transfer depend on?

A
  • molecular weight (smaller sizes will cross more easily)
  • polarity (unionised molecules cross more readily)
  • lipid solubility (lipid soluble drugs will cross)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how does foetal distribution differ from adults?

A

difference in:

  • circulation (umbilical vein to liver, relatively more blood flow to brain)
  • “free” drug available (less protein binding)
  • fat (less)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how does foetal metabolism differ from adults?

A
  • reduced enzyme activity

- different p450 isoenzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does foetal excretion differ from adults?

A

excretion is into amniotic fluid, this is swallowed and can allow recirculation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the mechanisms of teratogenicity?

A
  • folate antagonism
  • neural crest cell disruption
  • enzyme-mediated teratogenesis
  • endocrine disruption: sex hormones
  • oxidative stress
  • vascular disruption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are some drug associated problems in pregnancy

A
  • teratogenicity: 1st trimester (3-8 weeks organogenesis)

- fetotoxicity: 2nd & 3rd trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what problem is there with people who have chronic conditions?

A

often undertreated due to fear that the drugs will affect the pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe folate antagonism

A

key process in DNA formation and new cell production

drugs that affect folate metabolism:

  • block conversion of folate to THF by binding irreversibly to enzyme
  • block other enzymes in folate pathway

result: neural tube, oro-facial or limb defect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe neural crest cell disruption

A

caused by retinoid drugs

results in:

  • aortic arch anomalies
  • ventricular septal defects
  • craniofacial malformations
  • oesophageal atresia
  • pharyngeal gland abnormalities
17
Q

describe enzyme mediated teratogenesis?

A

drugs may interact with specific receptors and enzymes damaging foetal development

eg NSAIDs cause oro-facial clefts and cardiac septal defects

18
Q

what is fetotoxicity?

A

toxic effect on the foetus later in the pregnancy

19
Q

how are drugs stages for use in pregnancy?

A
  • A: No foetal risk
  • B: Animal studies show no risk but no human studies conducted
  • C: No human data
  • D: Evidence of foetal risk but benefits outweigh them
  • X: Foetal risk outweigh possible benefit
20
Q

examples of known teratogens to avoid during pregnancy

A

anticonvulsants -> neural tube defects
(valproate, carbamazepine, phenytoin)

anticoagulants -> haemorrhage, multiple malformations in CNS (warfarin)

antihypertensives -> renal damage, restrict normal growth patterns (ACEI)

NSAIDs -> premature closure of ductus arteriosus

alcohol -> foetal alcohol syndrome

retinoids -> ear, CNS, cardiovascular, and skeletal disorders

21
Q

what is the issue with drugs and lactation?

A

almost all drugs will be present in breast milk (important to know concentration)

22
Q

what drugs should be avoided when breast feeding?

A

anti-convulsants (not all)

immunosuppressants

cytotoxics

drugs of abuse (especially opiates)

amiodarone, lithium, radio-iodine

23
Q

what are the principles of prescribing for women of child-bearing age?

A

consider possibility of pregnancy and warn of possible risks

24
Q

what are the principles of prescribing pregnancy?

A

choose non-pharmacological treatments

pharmacological treatment: lowest dose, shortest duration, avoid first 10 weeks

check the SPC for the most up to date information

25
Q

what are the principles of prescribing in breast feeding?

A

avoid drugs

drugs: choose pharmacokinetic properties that reduce infant exposure (eg highly protein bound)

check on up to date drug information

26
Q

describe the exchange of materials across the placenta

A